When a cat gets a stuffy nose, it’s easy to assume a kitty cold is the culprit…especially if they’re also sneezing and ...

Dupilumab was effective for patients with severe chronic rhinosinusitis with nasal polyps (CRSwNP) at 52 weeks.

Patients with CRSwNP have a high burden of SCS use and associated health care costs, especially when they have comorbid asthma.

Celltrion today announced that Health Canada has approved Omlyclo™, a biosimilar referencing Xolair®. Omlyclo™ is approved ...

AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...

A new study published in the Ear, Nose and Throat Journal found that the severity of chronic rhinosinusitis with nasal ...

Comorbid asthma, nonsmoking status, and the ethmoid/maxillary sinus ratio were significant predictors of eosinophilic CRSwNP.

Discover how asthma contributes to bronchiectasis development through sinusitis and inflammation. Learn about new findings ...